HIV dementia: An evolving disease

Journal of Neuroimmunology

Volumn 157, Issue 1-2 SPEC. ISS., 2004, Pages 3-10

  McArthur, Justin C ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Associative markers; HAART; HIV dementia

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DEVELOPED COUNTRY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; EXPOSURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MEASUREMENT; MEMORY DISORDER; MONITORING; NERVOUS SYSTEM INJURY; NEUROPROTECTION; NEUROTOXICITY; PATIENT CARE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; SENSORY NEUROPATHY; SEROLOGY; SURVIVAL; SURVIVAL TIME; VIRUS REPLICATION; WORKING MEMORY;

AIDS DEMENTIA COMPLEX; AIDS-ASSOCIATED NEPHROPATHY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CLINICAL TRIALS; DISEASE PROGRESSION; HIV-1; HUMANS;

EID: 9644272621     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.08.042     Document Type: Conference Paper

References (57)

1. D.C. Adamson, J.C. McArthur, T.M. Dawson, and V.L. Dawson Rate and severity of HIV-associated dementia: correlations with gp41 and iNOS Mol. Med. 5 1999 98 109
2. S.M. Albert, C. Weber, and G. Todak An observed performance test of medication management ability in HIV: relation to neuropsychological status and adherence outcomes AIDS Behav. 3 1999 121 128
3. A. Andrade, H. Davis, S. Celano, L. Cheever, A. Wu, and R.L. Skolasky Intervention trial using a novel electronic device in HAART initiators: impact of cognitive dysfunction 8th Conference on Retroviruses and Opportunistic Infections 2001 Feb. 2-5, Chicago
4. J.A. Bartok, E.M. Martin, D.L. Pitrak, R.M. Novak, K.J. Pursell, and K.M. Mullane Working memory deficits in HIV-seropositive drug users J. Int. Neuropsychol. Soc. 3 1997 451 456
5. F.H. Bouwman, R. Skolasky, D. Hes, O.A. Selnes, J.D. Glass, and T.E. Nance-Sproson Variable progression of HIV-associated dementia Neurology 50 1998 1814 1820
6. B.J. Brew, L. Pemberton, P. Cunningham, and M.G. Law Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage J. Infect. Dis. 175 1997 963 966
7. B.J. Brew, M. Halman, J. Catalan, N. Sacktor, R.W. Price, S. Brown, J.H. Atkinson, D.B. Clifford, D. Simpson, G. Torres, C. Hall, C. Power, K. Marder, P. Portegies, J.C. McArthur, B. Symonds, and C. Romero Abacavir in AIDS Dementia Complex: Efficacy and Lessons for Future Trials Neurology 2000 (in press)
8. H.R. Brodt, B.S. Kamps, P. Gute, B. Knupp, S. Staszewski, and E.B. Helm Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy AIDS 11 1997 1731 1738
9. L. Chang, T. Ernst, C. St Hillaire, and K. Conant Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients Antivir. Ther. 9 2004 431 440
10. M. Cherner, E. Masliah, R.J. Ellis, T.D. Marcotte, D.J. Moore, and I. Grant Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis Neurology 59 2002 1563 1567
11. D.B. Clifford, J.C. McArthur, G. Schifitto, K. Kieburtz, M.P. McDermott, and S. Letendre A randomized, placebo-controlled phase II clinical trial of CPI-1189 for HIV-associated motor-cognitive impairment Neurology 59 2002 1568 1573
12. R.A. Cohen, R. Boland, R. Paul, K.T. Tashima, E.E. Schoenbaum, and D.D. Celentano Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women AIDS 15 2001 341 345
13. H.F. Davis, R.L. Skolasky Jr., O.A. Selnes, D.M. Burgess, and J.C. McArthur Assessing HIV-associated dementia: modified HIV dementia scale versus the grooved pegboard AIDS Read. 12 29-31 2002 38
14. A. De Luca, B.C. Ciancio, D. Larussa, R. Murri, A. Cingolani, and M.G. Rizzo Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals Neurology 59 2002 342 347
15. G.J. Dore, A. McDonald, Y. Li, J.M. Kaldor, and B.J. Brew Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy AIDS 17 2003 1539 1545
16. R.H. Dougherty, R.L. Skolasky, and J.C. McArthur Progression of HIV-associated dementia treated with HAART AIDS Read. 12 2002 69 74
17. R.J. Ellis, K. Hsia, S.A. Spector, J.A. Nelson, R.K. Heaton, and M.R. Wallace Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome Ann. Neurol. 42 1997 679 688
18. R.J. Ellis, D.J. Moore, M.E. Childers, S. Letendre, J.A. McCutchan, and T. Wolfson Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA Arch. Neurol. 59 2002 923 928
19. S. Fahn, C. Marsden, and D. Caine Recent Developments in Parkinson's Disease 1987 Macmillan Healthcare Information Florham Park, NJ
20. R. Farinpour, E.M. Martin, M. Seidenberg, D.L. Pitrak, K.J. Pursell, and K.M. Mullane Verbal working memory in HIV-seropositive drug users J. Int. Neuropsychol. Soc. 6 2000 548 555
21. S. Ferrando, J. Rabkin, W. van Gorp, and M. McElhiney Protease inhibitors are associated with less neuropsychological impairment in HIV infection (abstract 186) 5th Conference on Retroviruses and Opportunistic Infections 1998 113 Feb. 1-5, Chicago
22. S. Ferrando, W. van Gorp, M. McElhiney, K. Goggin, M. Sewell, and J. Rabkin Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function AIDS 12 1998 F65 F70
23. J.D. Glass, H. Fedor, S.L. Wesselingh, and J.C. McArthur Immunocytochemical quantitation of HIV in the brain: correlations with HIV-associated dementia Ann. Neurol. 38 1995 755 762
24. P.Y. Hsue, J.C. Lo, A. Franklin, A.F. Bolger, J.N. Martin, and S.G. Deeks Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection Circulation 109 2004 1603 1608
25. R.S. Janssen, A.J. Saykin, L. Cannon, J. Campbell, P.F. Pinsky, and N.A. Hessol Neurological and neuropsychological manifestations of HIV-1 infection: association with AIDS-related complex but not asymptomatic HIV-1 infection Ann. Neurol. 26 1989 592 600
26. R.S. Janssen, D.R. Cornblath, L.G. Epstein, R.P. Foa, J.C. McArthur, and R.W. Price Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force Neurology 41 1991 778 785
27. S. Letendre, J. Marquie-Beck, K. Singh, S. Spector, S. De Almeida, and J. Zimmerman The monocyte chemotactic protein-1-2578 G allele is associated with elevated MCP-1 concentrations in cerebrospinal 11th Conference on Retroviruses and Opportunistic Infections 2004 Feb. 8-11, San Francisco
28. S. Letendre, J. Zheng, C. Yiannoutsos, A. Lopez, R. Ellis, and J. Marquie-Beck Chemokines correlate with cerebral metabolites on magnetic resonace spectroscopy: a substudy of ACTG 301 and 700 (abstract 29) 11th Conference on Retroviruses and Opportunistic Infections 2004 Feb. 8-11, San Francisco
29. T.D. Marcotte, R.K. Heaton, T. Wolfson, M.J. Taylor, O. Alhassoon, and K. Arfaa The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group J. Int. Neuropsychol. Soc. 5 1999 579 592
30. E.M. Martin, T.S. Sullivan, R.A. Reed, T.A. Fletcher, D.L. Pitrak, and W. Weddington Auditory working memory in HIV-1 infection J. Int. Neuropsychol. Soc. 7 2001 20 26
31. R. Mayeux, Y. Stern, M.X. Tang, G. Todak, K. Marder, and M. Sano Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment Neurology 43 1993 176 182
32. J.C. McArthur Neurologic manifestations of AIDS Medicine (Baltimore) 66 1987 407 437
33. J.C. McArthur, D.R. Hoover, H. Bacellar, E.N. Miller, B.A. Cohen, and J.T. Becker Dementia in AIDS patients: incidence and risk factors Neurology 43 1993 2245 2252
34. J.C. McArthur, D.R. McClernon, M.F. Cronin, T.E. Nance Sproson, A.J. Saah, and M. St.Clair Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain Ann. Neurol. 42 1997 689 698
35. J.C. McArthur, M.P. McDermott, D. McClernon, C. St.Hillaire, K. Conant, and K. Marder Attenuated CNS infection in advanced HIV/AIDS with combination antiretroviral therapy Arch. Neurol. 2004 (in press)
36. J.C. McArthur, M.P. McDermott, D. McClernon, C. St.Hillaire, K. Conant, K. Marder, G. Schifitto, O.A. Selnes, N. Sacktor, Y. Stern, S. Albert, D. Palumbo, K. Kieburtz, J.A. deMarcaida, B. Cohen, and L.G. Epstein Attenuated CNS infection and immune activation in advanced HIV/AIDS Arch. Neurol. 2004 (in press)
37. B.A. Navia, E.S. Cho, C.K. Petito, and R.W. Price The AIDS dementia complex: II. Neuropathology Ann. Neurol. 19 1986 525 535
38. B.A. Navia, B.D. Jordan, and R.W. Price The AIDS dementia complex: I. Clinical features Ann. Neurol. 19 1986 517 524
39. R.W. Price, and J.J. Sidtis Evaluation of the AIDS dementia complex in clinical trials J. AIDS 3 Suppl. 2 1990 S51 S60
40. R.W. Price, C.T. Yiannoutsos, D.B. Clifford, L. Zaborski, A. Tselis, and J.J. Sidtis Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team AIDS 13 1999 1677 1685
41. N. Sacktor The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy J. Neurovirology 8 Suppl. 2 2002 115 121
42. N.C. Sacktor, and J.C. McArthur Prospects for therapy of HIV-associated neurologic disease J. Neurovirology 3 1997 89 101
43. N.C. Sacktor, H. Bacellar, D.R. Hoover, T.E. Nance-Sproson, O.A. Selnes, and E.N. Miller Psychomotor slowing in HIV infection. A predictor of dementia, AIDS, and death J. Neurovirology 2 1996 404 410
44. N.C. Sacktor, R.L. Skolasky, R.H. Lyles, D. Esposito, O.A. Selnes, and J.C. McArthur Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors J. Neurovirology 6 2000 84 88
45. N. Sacktor, R.H. Lyles, R. Skolasky, C. Kleeberger, O.A. Selnes, and E.N. Miller HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990-1998 Neurology 56 2001 257 260
46. N. Sacktor, P.M. Tarwater, R.L. Skolasky, J.C. McArthur, O.A. Selnes, and J. Becker CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing Neurology 57 2001 542 544
47. N. Sacktor, M.P. McDermott, K. Marder, G. Schifitto, O.A. Selnes, and J.C. McArthur HIV-associated cognitive impairment before and after the advent of combination therapy J. Neurovirology 8 2002 136 142
48. N. Sacktor, M. Wong, R. Skolasky, O. Selnes, A. Barnes, J. Creighton, N. Nakasujja, S. Musisi, E. Katabira, K. Robertson, J. McArthur, and A. Ronald The International HIV Dementia Scale: a new rapid screening test for HIV dementia 2004 Ref Type: Unpublished Work
49. G. Schifitto, K. Kieburtz, M.P. McDermott, J. McArthur, K. Marder, and N. Sacktor Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes Neurology 56 2001 415 418
50. G. Schifitto, M.P. McDermott, J.C. McArthur, K. Marder, N. Sacktor, and L. Epstein Incidence of and risk factors for HIV-associated distal sensory polyneuropathy Neurology 58 2002 1764 1768
51. J.J. Sidtis, C. Gatsonis, R.W. Price, E.J. Singer, A.C. Collier, and D.D. Richman Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial Ann. Neurol. 33 1993 343 349
52. K.A. Thompson, J.C. McArthur, and S.L. Wesselingh Correlation between disease progression and astrocyte apoptosis in HIV-associated dementia Ann. Neurol. 49 2001 745 752
53. V. Tozzi, P. Balestra, S. Galgani, P. Narciso, F. Ferri, and G. Sebastiani Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment AIDS 13 1999 1889 1897
54. V. Valcour, B. Shiramizu, C. Shikuma, P. Poff, M. Watters, J. Grove, O. Selnes, and N. Sacktor Neurocognitive function among older compared to younger HIV-1 seropositive individuals J. Neurovirology 8 2002 69 (Ref Type: Abstract)
55. M.W. Weiner, D.J. Meyerhoff, V. Cardenas-Nicolson, J. Kornak, C. Studholme, and D. Truran Progressive white matter loss suggests ongoing brain injury in ART-treated HIV+ patients (abstract 33LB) 11th Conference on Retroviruses and Opportunistic Infections 2004 Feb. 8-11, San Francisco
56. Y. Yang, S. Evans, R. Gulick, and D. Clifford AIDS Clinical Trials Group A5097s Team. Hepatitis C and neuropsychological function in treatment naive HIV-1-infected subjects-A5097s baseline analysis (abstract 26) 11th Conference on Retroviruses and Opportunistic Infections 2004 Feb. 8-11, San Francisco
57. M.C. Zink, G.D. Coleman, J.L. Mankowski, R.J. Adams, P.M. Tarwater, and K. Fox Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis J. Infect. Dis. 184 2001 1015 1021